Africa REACH welcomes news that Zimbabwe becomes the first African country to approve injectable PrEP

*This article is based off a press release distributed by DTHF partner, Africa REACH.   The Medicines Control Authority of Zimbabwe recently approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention, making Zimbabwe the first African country to authorize the once-every-two-months injectable PrEP drug. Zimbabwe has a PrEP program…